
Homocysteinemia is widely accepted as an independent risk factor for coronary and peripheral vascular disease. Quatrefolic®, as a source of active folate, is an important regulator of Hcy metabolism.
What does homocysteine have to do with folate?
Homocysteine (Hcy) is a common amino acid found in the bloodstream that serves as a critical intermediate in methylation cycle reactions.
A disruption of Hcy metabolism, with an increased risk of several pathologies, occurs when Hcy levels are greater than normal.
Quatrefolic® offers tangible advantages versus folic acid and can promote healthier heart life – better folate blood levels directly translate to lower Hcy levels, especially for people with MTHFR (methylenetetrahydrofolate reductase) polymorphism, which is approximately 40% of the global population. These genetic alterations can lead to an increase in homocysteine blood levels.
Gnosis maintains wide attention on what science supports on Hcy and folate: low levels of 5-MTHF, critically contribute to increasing circulating Hcy levels and a toxic accumulation in the bloodstream.
Latest news & videos

- Corporate
- Digestion & Gut
- News
- Jun 06, 2025
Biotic Live: A Successful First Edition Exploring the Power of Probiotic Yeasts
Gnosis by Lesaffre recently hosted the first edition of Biotic Live, a unique event...

- Mobility & Joint
- MyCondro®
- News
- Jun 05, 2025
Redefining Joint Health: Gnosis by Lesaffre Showcases MyCondro™ at CMA Innovation Day
At the recent Innovation Day seminar hosted by Complementary Medicines Australia (CMA), Gnosis by...

- MenaQ7®
- Mobility & Joint
- News
- Jun 02, 2025
Supplementation with Menaquinone-7 (as MenaQ7®) Slows the Progression of Coronary Artery Calcification
The first results from the VitaK-CAC Trial, “Menaquinone-7 Slows Down Progression of Coronary Artery...